In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations
Open Access
- 27 October 2025
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 20 (5) , 1253-1269
Abstract
Cancer‐associated fibroblasts (CAFs) are sought after as potential therapeutic targets due to their pro‐ and antitumorigenic functions, which are attributed to specializations in CAF subtypes. A precise targeting of specific subtypes would be required to design therapies that effectively modulate CAF phenotypes, necessitating translatable model systems to support target discovery efforts. However, not only is our knowledge of CAF heterogeneity in solid tumors lacking, particularly in pancreatic tumors, but the translatability of CAF models has also not been rigorously evaluated. Here, we develop a coculturing model with primary CAFs and immortalized tumor cell lines that can reliably represent CAF phenotypes observed in tumors, with correlations to immuno‐resistant and immunomodulatory phenotypes. Using single‐cell transcriptomics, we characterize the CAF subtype heterogeneity in the in vitro CAF cell lines isolated from pancreatic cancer patients and investigate the impact of perturbing potential stromal genes on different CAF subtypes. We also infer the continuum of state changes underlying the interconvertibility of CAF subtypes. Finally, we use immortalized CAF cell lines to perform single‐cell CRISPR perturbations of stromal targets, revealing the subtype‐specific effects of perturbations and the impact of model‐type selection on the translatability of insights.Keywords
Funding Information
- Merck
This publication has 50 references indexed in Scilit:
- Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell linesJournal of Proteomics, 2023
- The KEAP1-NRF2 pathway: Targets for therapy and role in cancerRedox Biology, 2023
- Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathwayNeoplasia, 2021
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapyCancer Cell, 2021
- Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune MicroenvironmentCell Metabolism, 2018
- Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic ScreensCell, 2016
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaCell, 2016
- Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α DownregulationCell Reports, 2015
- The architecture of fibroblast monolayers of different origin differentially influences tumor cell growthInternational Journal of Cancer, 2012
- Stromal biology of pancreatic cancerJournal of Cellular Biochemistry, 2007